Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine productionJulia A Brown, David M Dorfman, Feng-Rong Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2003
Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteinsFrederick L Moore, Jadwiga Jaruzelska, Mark S Fox, et al.
The American Journal of Surgical Pathology|July 16, 2014
Profile of CD103 expression in T-cell neoplasms: immunoreactivity is not restricted to enteropathy-associated T-cell lymphomaElizabeth A Morgan, German A Pihan, Jonathan W Said, et al.
Pharmacotherapy|July 2, 2013
Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopeniaKatelyn W Sylvester, John Fanikos, Kevin E Anger, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsiaErrol R Norwitz, Lawrence C Tsen, Joong Shin Park, et al.
Thyroid : Official Journal of the American Thyroid Association|March 19, 2017
Myocardial Induction of Type 3 Deiodinase in Dilated CardiomyopathyAri J Wassner, Rebecca H Jugo, David M Dorfman, et al.
Archives of Pathology & Laboratory Medicine|June 3, 2006
The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee StudyDavid M Dorfman, Marilyn M Bui, Raymond R Tubbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)Scott J Rodig, Jeremy S Abramson, Geraldine S Pinkus, et al.
JCI Insight|February 8, 2023
Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myelomaJana Jakubikova, Danka Cholujova, Gabor Beke, et al.
Archives of Pathology & Laboratory Medicine|February 20, 2015
Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists Flow Cytometry Proficiency Testing ProgramMichael Keeney, Jaimie G Halley, Daniel D Rhoads, et al.
Pageof 12